doi: 10.1128/JVI.64.9.4589-4592.1990.
Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells
Affiliations
- PMID: 2166833
- PMCID: PMC247935
- DOI: 10.1128/JVI.64.9.4589-4592.1990
Item in Clipboard
Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells
J Virol.
1990 Sep.
Abstract
Both CD4+ and CD8+ T cells are required for the clearance of virus from the central nervous system following infection with the JHM strain of mouse hepatitis virus. Development of antiviral antibodies requires the presence of CD4+ T cells but appears to play a minimal role in the reduction of virus. The data presented are consistent with the hypothesis that clearance of JHM virus is mediated by virus-specific CD8+ T cells, which appear to require the presence of CD4+ T cells.
Similar articles
-
T-cell-mediated clearance of mouse hepatitis virus strain JHM from the central nervous system.J Virol. 1989 Jul;63(7):3051-6. doi: 10.1128/JVI.63.7.3051-3056.1989. J Virol. 1989. PMID: 2542613 Free PMC article.
-
T cell-mediated clearance of JHMV from the central nervous system.Adv Exp Med Biol. 1990;276:557-63. doi: 10.1007/978-1-4684-5823-7_77. Adv Exp Med Biol. 1990. PMID: 1966449 Review. No abstract available.
-
Characterization of T cells expanded in vivo during primary mouse hepatitis virus infection in mice.J Vet Med Sci. 1996 May;58(5):431-7. doi: 10.1292/jvms.58.431. J Vet Med Sci. 1996. PMID: 8741603
-
CD4 T cells contribute to virus control and pathology following central nervous system infection with neurotropic mouse hepatitis virus.J Virol. 2008 Mar;82(5):2130-9. doi: 10.1128/JVI.01762-07. Epub 2007 Dec 19. J Virol. 2008. PMID: 18094171 Free PMC article.
-
Background paper. On the role of the immune response in the course of coronavirus JHM-induced encephalomyelitides in mice and rats.Adv Exp Med Biol. 1990;276:623-7. doi: 10.1007/978-1-4684-5823-7_85. Adv Exp Med Biol. 1990. PMID: 1966458 Review. No abstract available.
Cited by
-
Application of Antimicrobial Peptide LL-37 as an Adjuvant for Middle East Respiratory Syndrome-Coronavirus Antigen Induces an Efficient Protective Immune Response Against Viral Infection After Intranasal Immunization.Immune Netw. 2022 Sep 26;22(5):e41. doi: 10.4110/in.2022.22.e41. eCollection 2022 Oct. Immune Netw. 2022. PMID: 36381960 Free PMC article.
-
Virus-Specific Regulatory T Cells Persist as Memory in a Neurotropic Coronavirus Infection.J Immunol. 2022 Apr 15;208(8):1989-1997. doi: 10.4049/jimmunol.2100794. Epub 2022 Apr 1. J Immunol. 2022. PMID: 35365567 Free PMC article.
-
T cell responses to SARS-CoV-2 in humans and animals.J Microbiol. 2022 Mar;60(3):276-289. doi: 10.1007/s12275-022-1624-z. Epub 2022 Feb 14. J Microbiol. 2022. PMID: 35157219 Free PMC article. Review.
-
Intranasal immunization with a Middle East respiratory syndrome-coronavirus antigen conjugated to the M-cell targeting ligand Co4B enhances antigen-specific mucosal and systemic immunity and protects against infection.Vaccine. 2022 Jan 31;40(5):714-725. doi: 10.1016/j.vaccine.2021.12.057. Epub 2021 Dec 30. Vaccine. 2022. PMID: 34991928 Free PMC article.
-
Evaluating the role of chemokines and chemokine receptors involved in coronavirus infection.Expert Rev Clin Immunol. 2022 Jan;18(1):57-66. doi: 10.1080/1744666X.2022.2017282. Epub 2022 Jan 3. Expert Rev Clin Immunol. 2022. PMID: 34964406 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
